Naringenin is a powerful inhibitor of SARS-CoV-2 infection in vitro. (January 2021)
- Record Type:
- Journal Article
- Title:
- Naringenin is a powerful inhibitor of SARS-CoV-2 infection in vitro. (January 2021)
- Main Title:
- Naringenin is a powerful inhibitor of SARS-CoV-2 infection in vitro
- Authors:
- Clementi, Nicola
Scagnolari, Carolina
D'Amore, Antonella
Palombi, Fioretta
Criscuolo, Elena
Frasca, Federica
Pierangeli, Alessandra
Mancini, Nicasio
Antonelli, Guido
Clementi, Massimo
Carpaneto, Armando
Filippini, Antonio - Abstract:
- Graphical abstract: Schematic representation of TPC2 role, investigated through genetic ablation and drug blocker, in the inhibition of Coronaviruses release into the cells.
- Is Part Of:
- Pharmacological research. Volume 163(2021)
- Journal:
- Pharmacological research
- Issue:
- Volume 163(2021)
- Issue Display:
- Volume 163, Issue 2021 (2021)
- Year:
- 2021
- Volume:
- 163
- Issue:
- 2021
- Issue Sort Value:
- 2021-0163-2021-0000
- Page Start:
- Page End:
- Publication Date:
- 2021-01
- Subjects:
- Pharmacology -- Periodicals
Pharmacology -- Periodicals
Research -- Periodicals
Médicaments -- Recherche -- Périodiques
Pharmacologie -- Périodiques
615.105 - Journal URLs:
- http://www.sciencedirect.com/science/journal/10436618 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.phrs.2020.105255 ↗
- Languages:
- English
- ISSNs:
- 1043-6618
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 6446.550000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 23100.xml